Results 61 to 70 of about 4,518,702 (324)

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Ultra-processing markers are more prevalent in plant-based meat products as compared to their meat-based counterparts in a German food market analysis

open access: yesPublic Health Nutrition, 2023
Objective: To compare ultra-processing markers and nutrient composition in plant-based meat products (PBMP) with equivalent meat-based products (MBP). Design: A total of 282 PBMP and 149 MBP within 18 product categories were assessed. Based on the NOVA
Kemja-Maria Metz   +2 more
doaj   +1 more source

Parametrized higher category theory

open access: yesAlgebraic & Geometric Topology, 2023
We develop foundations for the category theory of $\infty$-categories parametrized by a base $\infty$-category. Our main contribution is a theory of indexed homotopy limits and colimits, which specializes to a theory of $G$-colimits for $G$ a finite group when the base is chosen to be the orbit category of $G$. We apply this theory to show that the $G$-
openaire   +2 more sources

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Higher Toda brackets and the Adams spectral sequence in triangulated categories

open access: yes, 2017
The Adams spectral sequence is available in any triangulated category equipped with a projective or injective class. Higher Toda brackets can also be defined in a triangulated category, as observed by B. Shipley based on J.
Christensen, J. Daniel   +1 more
core   +1 more source

Criterion‐Related Validity of the Neuropsychological Quick Assessment for Screening Cognitive, Motor, and Behavioral Impairments in Patients With Pediatric Brain Tumors: An Observational Pilot Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata   +9 more
wiley   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Algebraic K-theory of stable $\infty$-categories via binary complexes

open access: yes, 2019
We adapt Grayson's model of higher algebraic $K$-theory using binary acyclic complexes to the setting of stable $\infty$-categories. As an application, we prove that the $K$-theory of stable $\infty$-categories preserves infinite products.Comment: 20 ...
Kasprowski, Daniel, Winges, Christoph
core   +1 more source

Home - About - Disclaimer - Privacy